Efficacy and Safety Study of PEG-IFN-SA and Ribavirin to Treat Chronic Hepatitis C

PHASE3CompletedINTERVENTIONAL
Enrollment

719

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

August 31, 2015

Study Completion Date

August 31, 2015

Conditions
Chronic Hepatitis c
Interventions
DRUG

PEG-IFN-SA /RBV

DRUG

Pegasys /RBV

Trial Locations (41)

Unknown

First Affiliated Hospital of Lanzhou University, Lanzhou

Guangzhou Eighth People's Hospital, Guangzhou

Nanfang Hospital Southern Medical Unbiversity, Guangzhou

The First Affiliated Hospital of Guangxi Medical University, Nanning

Third Affiliated Hospital, Hebei Medical University, Shijiazhuang

The Second Affiliated Hospital of Harbin Medical University, Harbin

The First Affiliated Hospital of Xinxiang Medical University, Xinxiang

Henan Provincial People's Hospital, Zhengzhou

Tongji Hospital, Tongji Medical College Huazhong University of Science & Technology, Wuhan

Union hospital, Tongji Medical College Huazhong University of Science & Technology, Wuhan

Zhongnan Hospital of Wuhan University, Wuhan

The Second Xiangya Hospital of Central South University, Changsha

Xiangya Hospital Central-South University, Changsha

Jiangsu province hospital, Nanjing

The Second Hospital of Nanjing, Nanjing

First Affiliated Hospital of Nanchang University, Nanchang

The First Affiliated Hospital of Jilin University, Changchun

Yanbian University Hospital (Yanbian Hospital), Yanji

The Sixth People's Hospital of Shenyang, Shenyang

First Affiliated Hospital Of Medical College of Xian Jiaotong University, Xi'an

Second Affiliated Hospital Of Medical College of Xian Jiaotong University, Xi'an

Tangdu Hospital,Fourth Military Medical University, Xi'an

Jinan Infectious Disease Hospital, Jinan

Qilu Hospital of Shandong university, Jinan

Qingdao Municipal Hospital, Qingdao

The First Hospital of Shanxi Medical University, Taiyuan

Sichuan Academy of Medical Science &Sichuan Provincial People's Hospital, Chengdu

West China Hospital, Sichuan University, Chengdu

The First Teaching Hospital of Xinjiang Medical University, Ürümqi

The First Affiliated Hospital of Wenzhou Medical University, Wenzhou

302 Military Hospital of China, Beijing

Beijing Ditan Hospital, Capital Medical University, Beijing

Beijing Youan Hospital, Capital Medical University, Beijing

Beijing Youyi Hospital, capital Medical University, Beijing

General Hospital of Beijing Military Region, Beijing

Peking University First Hospital, Beijing

Peking University People's Hospital, Beijing

Chongqing Southwest Hospital, Chongqing

The Second Affiliated Hospital of Chongqing Medical University, Chongqing

Shanghai Public Health Clinical Center, Shanghai

Tianjin Infectious Disease Hospital, Tianjin

All Listed Sponsors
lead

Beijing Kawin Technology Share-Holding Co., Ltd.

INDUSTRY

NCT01903278 - Efficacy and Safety Study of PEG-IFN-SA and Ribavirin to Treat Chronic Hepatitis C | Biotech Hunter | Biotech Hunter